Only 2% of patients with primary sclerosing cholangitis (PSC) received a cholangiocarcinoma diagnosis, and the diagnosis was not early enough for there to be a survival benefit. In patients with PSC, ...
New Partnership Provides Unparalleled Insights for PSC Patients and Providers GREENWOOD VILLAGE, Colo.–(BUSINESS WIRE)–February 20, 2019– PSC Partners Seeking a Cure announced today a partnership with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback